BOARD OF DIRECTORS
The Cancer Research & Treatment Fund (CR&T) is led by a Board of Directors that is supported by our Medical Advisory Board. Together, they represent a broad cross-section of specialties and disciplines, working together to rapidly deploy funding to the frontlines of research and ensuring CR&T maintains its reputation as a leading voice in cancer research.
Thomas M. Silver, President
Executive Chairman, Bright Funds
Richard T. Silver, MD, Vice President, Medical Director
New York-Presbyterian/Weill Cornell Medicine
Joseph N. Aimi
President, Kenneth Bieber, Inc.
Henry J. Amoroso, Esq.
Partner, Chiesa Shahinian & Giantomasi PC
David T. Boule
Retired Partner, Ernst & Young
Maria Brisbane, CFA
Managing Director, Merrill Lynch
Auburn Enlarged City School System (Retired)
President, Mr. Christmas, Inc.
Michael C. Kempner
Managing General Partner, KS Capital Partners, LP
Douglas W. McCormick
Board President, Rho Capital Partners, LP
Amanda Johns Perez
Richard J. Rose
Sr. Managing Director, Retired, Shufro, Rose & Co., LLC
Todd J. Shaw
Senior Vice President, Morgan Stanley
Bharat Shah, PhD
Past President, Noble Investment Group (Retired)
Strategy/Business Development Manager, Pure Storage
Sr. Managing Member, Bennett Management
Associate, Lazard Asset Management, LLC
Nelson A. Boxer
Petrillo Klein & Boxer LLP